Kiox Pharmaceuticals ApS Financials, key figures and credit report
Gross profit 120.5 kDKK FY 2025 +129.3% vs 2024
EBIT - 832.9 kDKK FY 2025 +65.5% vs 2024
Net debt 329.5 kDKK FY 2025 +253.3% vs 2024
Quick ratio 0.7 FY 2025 -0.7 vs 2024
Income statement (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Other operating income | 573.55 | 300.34 | ||
| External services | -2.63 | - 161.44 | - 411.76 | - 179.87 |
| Gross profit | -2.63 | 412.11 | - 411.76 | 120.47 |
| Other operating expenses | -1 651.58 | -2 001.37 | - 953.37 | |
| EBIT | -2.63 | -1 239.47 | -2 413.13 | - 832.90 |
| Other financial income | 2.48 | 29.94 | 1.69 | |
| Other financial expenses | -0.26 | -5.31 | -3.11 | -6.89 |
| Pre-tax profit | -2.89 | -1 242.30 | -2 386.31 | - 838.10 |
| Income taxes | 273.31 | 545.28 | 198.56 | |
| Net earnings | -2.89 | - 968.99 | -1 841.03 | - 639.54 |
Assets (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 20.00 | |||
| Prepayments and accrued income | 280.16 | |||
| Current other receivables | 359.55 | 32.37 | 115.85 | |
| Current deferred tax assets | 273.31 | 545.28 | 198.56 | |
| Short term receivables total | 20.00 | 632.86 | 577.65 | 594.57 |
| Cash and bank deposits | 17.11 | 172.13 | 206.73 | 560.50 |
| Cash and cash equivalents | 17.11 | 172.13 | 206.73 | 560.50 |
| Balance sheet total (assets) | 37.11 | 804.99 | 784.38 | 1 155.07 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Share capital | 40.00 | 208.00 | 225.83 | 225.83 |
| Retained earnings | 697.11 | 1 850.37 | 9.34 | |
| Profit of the financial year | -2.89 | - 968.99 | -1 841.03 | - 639.54 |
| Shareholders equity total | 37.11 | -63.88 | 235.17 | - 404.37 |
| Non-current liabilities total | ||||
| Current trade creditors | 868.87 | 249.21 | 366.84 | |
| Current owed to participating | 300.00 | 890.00 | ||
| Accruals and deferred income | 302.60 | |||
| Current liabilities total | 868.87 | 549.21 | 1 559.44 | |
| Balance sheet total (liabilities) | 37.11 | 804.99 | 784.38 | 1 155.07 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated